Business Review Board

Members from two different advisory groups, the Scientific Review Board and the Business Review Board, review all grant applications submitted to the ADDF. The Business Review Board comprises members from various backgrounds, including venture capital and the biotechnology and pharmaceutical industry.

  • Denise Barbut, MD, MRCP
    Sarentis Therapeutics, Inc

  • Thomas Cirrito, PhD
    Stemline Therapeutics, Inc.

  • Mark A. Cochran, PhD
    Johns Hopkins University School of Medicine

  • Steven G. Dickman
    CBT Advisors

  • Julie Eskay-Eagle, MBA
    Vice President of Strategy and Corporate Development, Real Endpoints

  • Stephen M. Goodman, JD
    Pryor Cashman Sherman & Flynn, LLP

  • Allan M. Green, MD, PhD, JD
    Allan M. Green Esq., LLC

  • Emer Leahy, PhD, MBA
    Psychogenics Inc.

  • Michael Lefenfeld
    SiGNa Chemistry, Inc.

  • David Lowe, PhD
    NeuroAssets

  • Brian McCarthy, PhD
    Influmedix, Inc.

  • Ian J. Mehr, PhD, MBA
    Golden Pine Ventures, LLC

  • Michael Parker, MBA
    BioAsset Advisors

  • Rana Quraishi, PhD
    Capco

  • Teresa Reguly, PhD, JD
    Torys LLP